Related Experiment Video
Updated: Jun 12, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Azathioprine-Induced Acute Sialadenitis and Pancreatitis in a Patient With Ulcerative Colitis
Mio Namikawa1, Makoto Okabe1, Kenji Wakasugi1
1Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Japan.
None:
A 38-year-old woman with a five-year history of ulcerative colitis (UC) treated with 5-aminosalicylic acid presented with an acute flare of UC. The patient was treated with azathioprine (AZA) as maintenance therapy following budesonide rectal foam and developed AZA-induced sialadenitis and pancreatitis. To the best of our knowledge, this is the first reported case of concomitant azathioprine-induced sialadenitis and pancreatitis, highlighting the possibility of a shared immunologically mediated hypersensitivity mechanism. This case highlights the impact of idiosyncratic hypersensitivity reactions in thiopurine toxicity and provides clinically relevant insights into the safe application of AZA for inflammatory bowel disease management.
More Related Videos
08:51Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Pathophysiology
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...